5Vicent A, Bowen J, Newsom-Davis J, et al. Seronegative general- ized myasthenia gravis: eliniealfeatures, antibodies, and their tar- gets[J]. Lancet Neurol, 2003,2 (2) : 99. 被引量：1
6Suzuki S,Utsugisawa K,Nagane Y,et al. Three types of striation- al antibodies in myasthenia gravis[J]. Autoimmune Dis, 2011, 740583. 被引量：1
7Romi F, Skeie GO, Aarli JA, et al. The severity of myasthenia gra- vis correlates with the serum concentration of titin and ryanodine receptor antibodies[J]. Arch Neurol, 2000,57 (11) : 1956. 被引量：1
8Romi F,Aarli JA,Gilhus NE. Myasthenia gravis patients with ry anodine receptor antibodies have distinctive clinical features[J]. Eur J Neurol,2007,14(6) :617. 被引量：1
9Suzuki S, Utsugisawa K, Nagane Y, et al. Classification of myas- thenia gravis based on. 被引量：1
3Romi F, Skeie GO, Aarli JA, et al. The severity of myasthenia gravis correlates with the serum concentration of Titin and Ryanodine receptor antibodies. Arch Neurol, 2000, 57: 1596- 1600. 被引量：1
4De Meis L, Hasselbach W. Aceryl phosphate as substrate for Ca^2+ take in skeletal muscle microsomes. Inhibition by alkali ions. J Biol Chemi, 1971, 246: 4759-4763. 被引量：1
5Skeie GO, Bartoccioni E, Evoli A, et al. Ryanodine receptor antibodies are associated severe myasthenia gravis. Ner J Neurol, 1996,3 : 136-140. 被引量：1
7Romi F, Bo L, Skeie GO, et al. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol,2002, 128 : 82-89. 被引量：1
8Mygland A, Kuwajima G, Mikoshiba K, et al. Thymomas express epitopes shared by the ryanodine receptor. J Neuroimmunol, 1995, 62 : 79 -83. 被引量：1
